Bullish, a regulated and security-focused CEX, has been integrated into SwissBorg’s Meta-Exchange (MEX), increasing the platform’s liquidity network and enhancingBullish, a regulated and security-focused CEX, has been integrated into SwissBorg’s Meta-Exchange (MEX), increasing the platform’s liquidity network and enhancing

SwissBorg Integrates Bullish Into Meta-Exchange to Boost Liquidity and Execution

  • The Meta-Exchange uses SwissBorg’s Smart Engine to combine sophisticated decentralized exchange routing with liquidity from top centralized exchanges.
  • The integration is intended to lower slippage on bigger transactions, increase execution dependability, especially during times of increased market volatility.

Bullish, a regulated and security-focused CEX, has been integrated into SwissBorg’s Meta-Exchange (MEX), increasing the platform’s liquidity network and enhancing best-execution capabilities for customers. SwissBorg is the leading app in Europe for cryptocurrency investment and earning.

Bullish adds significant order book depth to popular stablecoins, Bitcoin, Ether, and XRP, among other assets. SwissBorg’s Meta-Exchange combines a wider variety of centralized and decentralized exchanges by integrating Bullish, which enhances price discovery and execution in a variety of market situations.

The Meta-Exchange uses SwissBorg’s Smart Engine to combine sophisticated decentralized exchange routing with liquidity from top centralized exchanges. The system may assess more markets in real time with Bullish included, which raises the possibility of obtaining the best price for each trade. Additionally, SwissBorg may now offer several tokens that were not previously accessible in its Marketplace because to the increased liquidity pool.

Founded in 2021, Bullish is a worldwide digital asset exchange that prioritizes operational rigor, security, and compliance. The firm is renowned for its reliable liquidity across blue-chip digital assets and institutional-grade infrastructure. Its strategy complements SwissBorg’s focus on user safety, transparency, and trustworthy financial instruments.

The integration is intended to lower slippage on bigger transactions, increase execution dependability, especially during times of increased market volatility, and further enhance overall pricing for SwissBorg customers. In times of rapid market movement, high-liquidity centralized exchanges are essential for preserving steady pricing and reliable order fulfillment.

Additionally, SwissBorg will be able to support more tokens that their community was previously unable to access thanks to access to the Bullish order book.

Without having to manage many accounts or platforms, customers may access this pooled liquidity via a single interface thanks to the Meta-Exchange. To get the best possible result, orders are automatically routed across related venues, including Bullish.

SwissBorg keeps growing its network of liquidity on both decentralized and centralized exchanges. A rising number of integrated providers covering many blockchains, including as Base, Solana, Avalanche, Berachain, BNB Chain, and Hyperliquid, have joined Bullish. There are presently more network expansions and mergers underway.

The top community-driven cryptocurrency wealth management platform is SwissBorg, which was developed in Switzerland and has an EU license. SwissBorg is dedicated to openness and trust, and its goal is to democratize the future of finance so that everyone may achieve financial independence. At its heart is the innovative Meta-Exchange, which easily links to a number of decentralized and centralized exchanges to provide customers the greatest pricing and liquidity. In addition to trading, SwissBorg enables customers to access early Web3 possibilities via its Alpha Pre-Sales and provides tailored yield strategies with DeFi. At the center of their ecosystem, Swissborg’s token, BORG, offers its holders a host of advantages.

Bullish (NYSE: BLSH) is a worldwide digital asset platform with an institutional emphasis that offers information services and regulated market infrastructure. Among them is Bullish Exchange, a spot and derivatives exchange for digital assets with an institutional emphasis that combines automated market making with a high-performance central limit order book matching engine to provide deep and reliable liquidity. As a cryptocurrency asset service provider that offers spot trading and custody services for digital assets, Bullish Europe is regulated by MiCAR.

Market Opportunity
Bullish Degen Logo
Bullish Degen Price(BULLISH)
$0.01439
$0.01439$0.01439
-7.45%
USD
Bullish Degen (BULLISH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26